Otsuka Holdings Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended June 30, 2021
August 06, 2021 at 12:30 am EDT
Share
Otsuka Holdings Co., Ltd. announced consolidated earnings results for the six months ended June 30, 2021. For the period, the company reported net sales of JPY 718,815 million compared to JPY 695,443 million a year ago. Operating profit was JPY 111,169 million compared to JPY 118,008 million a year ago. Profit for the period was JPY 93,700 million compared to JPY 88,511 million a year ago. Basic earnings per share was JPY 168.53 compared to JPY 160.08 a year ago. Diluted earnings per share was JPY 167.68 compared to JPY 158.56 a year ago.
Otsuka Holdings Co, Ltd. is a holding company organised around 4 areas of activity:
- manufacture and sale of pharmaceutical products (65.2% of sales): prescription drugs and intravenous solutions mainly for the treatment of central nervous system disorders, cancer, cardiovascular, gastrointestinal and ophthalmic diseases. In addition, the group sells diagnostic products and medical devices;
- manufacture and sale of nutraceutical products (25.1%): functional foods and beverages, OTC products, nutritional supplements;
- production of mineral waters, beverages and foods (2.1%);
- other (7.5%): manufacture of functional chemicals and fine chemicals, provision of logistics services, manufacture of electronic products, etc.
Net sales by source of income are divided between sales of products (93.8%), sales of licences and royalties (1.8%) and other (4.4%).
Net sales are distributed geographically as follows: Japan (43.2%), North America (34%),
OTSUKA HOLDINGS CO., LTD. 
